Chemokine Ligand-3 (CCL3) as a Novel Mediator of Inflammatory Bowel Disease Activity

Gastro Hep Advances · Published 2026-08-01 · DOI 10.1016/j.gastha.2026.101081

Free full text

Authors (6)

Eileen O’Brien, Kyra Fine, Olimpia Sienkiewicz, Yuhong Wei, Christine E. Orr, Daniel J. Mulder

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

O’Brien, E., Fine, K., Sienkiewicz, O., et al. (2026). Chemokine Ligand-3 (CCL3) as a Novel Mediator of Inflammatory Bowel Disease Activity. Gastro Hep Advances. https://doi.org/10.1016/j.gastha.2026.101081

Related articles